ERBB2 and central nervous system cancer: ERBB2 gene enrichment was correlated with a poor prognosis of cancer patients in some primary tumors, such as glioblastoma, low-grade glioma, ovarian cancer, and skin cutaneous melanoma (Figure 1C).